The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Interpreting patient-reported outcome results: US FDA guidance and emerging methods
Open accessAbstract
In recent years, the US FDA has become more critical of instruments used to measure patient-reported outcomes (PROs) in clinical trials. To facilitate decisions related to the approval of drugs, labels and promotional claims based on PROs, the FDA created the Study Endpoints and Label Development (SEALD) group. SEALD has developed a PRO guidance related to the use of PRO measures used to support drug approvals and label claims, including recommendations for establishing thresholds for meaningful change at the individual level (i.e., defining a responder). This article examines in detail the FDA-recommended methodology for defining a responder and analyzing responder-based PRO measure results. We also present other responder analysis approaches for consideration in furthering the precision and interpretation of this methodology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanley, J. A., & McNeil, B. J. (1983) · Radiology · doi:10.1148/radiology.148.3.6878708 · Cited by 7,016
Farrar, J. T., Young, J. P., LaMoreaux, L., Werth, J. L., & Poole, M. R. (2001) · Pain · doi:10.1016/s0304-3959(01)00349-9 · Cited by 5,808
Determining a minimal important change in a disease-specific quality of life questionnaire
JUNIPER, E. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90036-1 · Cited by 1,824
Wyrwich, K. W., Tierney, W. M., & Wolinsky, F. D. (1999) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(99)00071-2 · Cited by 862
Walters, S. J., & Brazier, J. E. (2003) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-1-4 · Cited by 441
Hays, R. D., Farivar, S. S., & Liu, H. (2005) · COPD: Journal of Chronic Obstructive Pulmonary Disease · doi:10.1081/copd-200050663 · Cited by 250
Self-citationFarrar, J. T., Dworkin, R. H., & Max, M. B. (2006) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2005.08.018 · Cited by 138
Hays, R. D., Brodsky, M., Johnston, M. F., Spritzer, K. L., & Hui, K.-K. P. (2005) · Evaluation & the Health Professions · doi:10.1177/0163278705275339 · Cited by 111
Self-citationConclusions About Frequently Studied Modified Angoff Standard-Setting Topics
Brandon, P. R. (2004) · Applied Measurement in Education · doi:10.1207/s15324818ame1701_4 · Cited by 88
McLeod, L., Fehnel, S. E., Brandman, J., & Symonds, T. L. (2003) · PharmacoEconomics · doi:10.2165/00019053-200321150-00001 · Cited by 30
Self-citation
Cited by
Guidelines for designing and evaluating feasibility pilot studies
Teresi, J. A., Yu, X., Stewart, A. L., & Hays, R. D. (2022) · Medical Care · doi:10.1097/mlr.0000000000001664 · Cited by 734
Report of the NIH Task Force on research standards for chronic low back pain.
Deyo, R. A., Dworkin, S. F., Amtmann, D., Andersson, G., Borenstein, D., Carragee, E., Carrino, J., Chou, R., Cook, K., DeLitto, A., et al. (2014) · The Journal of Pain · doi:10.1016/j.jpain.2014.03.005 · Cited by 533
Gossec, L., de Wit, M., Kiltz, U., Braun, J., Kalyoncu, U., Scrivo, R., Maccarone, M., Carton, L., Otsa, K., Sooäär, I., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-205207 · Cited by 413
Yosipovitch, G., Reaney, M., Mastey, V., Eckert, L., Abbé, A., Nelson, L., Clark, M., Williams, N., Chen, Z., Ardeleanu, M., et al. (2019) · British Journal of Dermatology · doi:10.1111/bjd.17744 · Cited by 394
Sedaghat, A. R. (2019) · Otolaryngology–Head and Neck Surgery · doi:10.1177/0194599819852604 · Cited by 393
Metadata
- Authors
- McLeod, L. D., Coon, C. D., Martin, S. A., Fehnel, S. E., & Hays, R. D.
- Venue
- Expert Review of Pharmacoeconomics & Outcomes Research
- Publisher
- Informa UK Limited
- Published
- 2011-04
- Volume
- 11
- Issue
- 2
- Pages
- 163-169
- ISSN
- 1473-7167 (ISSN-L)
- 1744-8379
- OpenAlex
- W2090233921
- Cited by
- 320
- References
- 10
- FWCI
- 12.80
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.